Skip to main content

DUBLIN, January 28, 2022 /PRNewswire/ — The “Clinical Research Services Market Research Report by Services, By Indication, By Deployment, By End User, By Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” has been added to from offer.

The global clinical research services market size has been estimated at $44.07 billion in 2020, is expected to reach $48.01 billion in 2021, and is expected to grow at a CAGR of 9.31% to reach $82.19 billion by 2027.

Market statistics:

The report provides market size analysis and forecasts for five major currencies – USD, EUR GBP, JPY and AUD. It helps organizational leaders make better decisions when currency data is readily available. In this report, the years 2018 and 2019 are considered as historical years, 2020 as the base year, 2021 as the estimated year and the years from 2022 to 2027 as the forecast period.

Competitive Strategy Window:

The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.

FPNV positioning matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Clinical Research Services Market based on business strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Customer Satisfaction. product (value for money, ease of use, product features and customer). Support) that helps businesses make better decisions and understand the competitive landscape.

Market share analysis:

The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of ​​its revenue generation in the overall market compared to other providers in the space. It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of ​​the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.

Enterprise Usability Profiles:

The report thoroughly explores recent significant developments by leading vendors and innovation profiles in the global clinical research services market including Acculab Lifesciences, America Holdings, Ardent CRO, Axcent Advanced Analytics (A3), Azelix, BIO Agile Therapeutics, Charles River Laboratories International Inc., Covance Inc., CROISSANCE CLINICAL RESEARCH, CTSERV, Dove Quality Solutions, Firma Clinical Research, Fisher Clinical Services, Inc., ICON plc, IQVIA, LabCorp, Medpace Holdings, Parexel International Corporation, PEPGRA, Pharmaceutical Product Development, LLC, PRA Health Sciences, PSI CRO AG, SGS SA, Syneos Health and Wuxi AppTec Inc..

The report provides information about the following pointers:

1. Market Penetration: Provides comprehensive information about the market offered by major players

2. Market Development: Provides detailed information on lucrative emerging markets and analyzes penetration in mature market segments

3. Market Diversification: Provides detailed information on new product launches, untapped geographies, recent developments and investments

4. Competitive Assessment and Intelligence: Provides a comprehensive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of key players

5. Product Development and Innovation: Provides smart insights into future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the global clinical research services market?

2. What are the inhibiting factors and impact of COVID-19 on the global clinical research services market during the forecast period?

3. What are the products/segments/applications/areas to invest in during the forecast period in the Global Clinical Research Services Market?

4. What is the competitive strategic window for opportunities in the Global Clinical Research Services Market?

5. What are the technology trends and regulatory frameworks in the global clinical research services market?

6. What is the market share of the major vendors in the global clinical research services market?

7. What modes and strategic moves are considered suitable for entering the global clinical research services market?

Main topics covered:

1. Preface

2. Research methodology

3. Executive Summary

4. Market Overview

5. Market Overview

5.1. Market dynamics

5.1.1. Drivers Rapid technological advancements and increasing globalization are encouraging biotech and pharmaceutical companies Demand for Effective Medicines and Health Devices Increase in patient population

5.1.2. Constraints High cost associated with product development

5.1.3. Opportunities Increase investment in research and development activities Develop strategic collaboration between companies

5.1.4. Challenges Rigorous drug approval process

5.2. Cumulative impact of COVID-19

6. Clinical Research Services Market, By Services

6.1. introduction

6.2. Clinical tests

6.3. Diagnostic research

6.4. Drug development consultancy

6.5. Epidemiological studies

6.6. Genetic studies

6.7. Preclinical studies

6.8. Prevention research

6.9. Quality of life research

6.10. Screening research

6.11. Treatment seeking

7. Clinical Research Services Market, By Indication

7.1. introduction

7.2. CNS disorders

7.3. Cardiovascular disorders

7.4. Diabetes

7.5. Infectious diseases

7.6. Oncology

8. Clinical Research Services Market, By Deployment

8.1. introduction

8.2. internally

8.3. Outsource

9. Clinical Research Services Market, By End User

9.1. introduction

9.2. Advanced pathologies

9.3. Contract research organizations

9.4. Medical device companies

9.5. Pharmaceutical and biopharmaceutical companies

10. Americas Clinical Research Services Market

10.1. introduction

10.2. Argentina

10.3. Brazil

10.4. Canada

10.5. Mexico

10.6. United States

11. Asia Pacific Clinical Research Services Market

11.1. introduction

11.2. Australia

11.3. China

11.4. India

11.5. Indonesia

11.6. Japan

11.7. Malaysia

11.8. Philippines

11.9. Singapore

11.10. South Korea

11.11. Taiwan

11.12. Thailand

12. Europe, Middle East & Africa Clinical Research Services Market

12.1. introduction

12.2. France

12.3. Germany

12.4. Italy

12.5. Netherlands

12.6. Qatar

12.7. Russia

12.8. Saudi Arabia

12.9. South Africa

12.10. Spain

12.11. United Arab Emirates

12.12. UK

13. Competitive landscape

13.1. FPNV positioning matrix

13.1.1. Quadrants

13.1.2. Business strategy

13.1.3. Product Satisfaction

13.2. Market Ranking Analysis

13.3. Market share analysis, by key player

13.4. Competitive scenario

13.4.1. Merger & Acquisition

13.4.2. Agreement, collaboration and partnership

13.4.3. Launching and improving new products

13.4.4. Investment & Financing

13.4.5. Reward, recognition and expansion

14. Company Usability Profiles

14.1. Acculab Life Sciences

14.2. America Holdings

14.3. fiery CRO

14.4. Axcent Advanced Analytics (A3)

14.5. Azelix

14.6. Therapeutic BIO Agile

14.7. Charles River International Laboratories Inc.

14.8. Covance Inc.


14.10. CTSERV

14.11. Dove quality solutions

14.12. Clinical Research Firma

14.13. Fisher Clinical Services, Inc.

14.14. SA ICON

14.15. IQVIA

14.16. LabCorp

14.17. Medspace Holdings

14.18. Parexel International Corporation

14.19. PEPGRA

2:20 p.m. Pharmaceutical Product Development, LLC

14.21. PRA Health Sciences

14.22. PSI CR AG

14.23. SGS S.A.

14.24. Syneos Health

2:25 p.m. Wuxi AppTec Inc.

15. Appendix

For more information about this report visit

Media Contact:

Research and Markets

Laura Woodsenior

[email protected]

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1907

Fax (outside the US): +353-1-481-1716

View original content:—featuring-acculab-lifesciences-azelix-and – icon-among-others-301470540.html

SOURCE Research and Markets